How AI Is Transforming Drug Discovery
Pharmacovigilance (PV) systems are designed to continuously monitor the safety of medicinal products throughout their lifecycle. In a highly regulated pharmaceutical environment, companies must follow strict procedures and timelines to meet regulatory expectations and protect patient safety.
However, even with well-established systems, deviations from approved procedures may occasionally occur. Effective deviation management helps organizations identify, investigate, and correct such departures while maintaining compliance with pharmacovigilance regulations.
What is a Deviation in Pharmacovigilance?
A deviation refers to any departure from approved procedures, regulatory requirements, or internal quality standards within a pharmacovigilance system.
Examples of PV Deviations
- Late submission of Individual Case Safety Reports (ICSRs)
- Delays in literature monitoring or signal detection
- Errors in case processing or safety data entry
- Failure to follow Standard Operating Procedures (SOPs)
- Delayed submission of periodic safety reports such as PSUR or PBRER
Deviations are typically classified based on their impact:
- Minor: Limited operational impact
- Major: Significant impact on pharmacovigilance activities
- Critical: Potential risk to patient safety or regulatory compliance
Proper classification helps prioritize investigation and corrective actions.
Why Deviation Management is Important
Deviation management is a key component of pharmacovigilance quality systems. A structured approach helps organizations:
- Maintain compliance with regulatory authorities
- Identify weaknesses in pharmacovigilance processes
- Prevent recurrence of operational issues
- Protect patient safety
- Demonstrate strong quality oversight during regulatory inspections
Regulatory frameworks such as Good Pharmacovigilance Practices (GVP) emphasize the importance of deviation management and corrective action systems.
Investigation and Corrective Actions
When a deviation is identified, it should be documented and investigated to determine the root cause. Quality teams often use structured methods such as Five Whys analysis or process reviews to identify underlying issues.
Once the root cause is identified, organizations implement Corrective and Preventive Actions (CAPA) to resolve the issue and prevent similar deviations in the future.
Examples of CAPA Actions
- Additional staff training
- Updating Standard Operating Procedures
- Improving workflow monitoring systems
- Strengthening quality oversight
Regulatory Expectations
Health authorities expect pharmaceutical companies to maintain a strong pharmacovigilance quality system. During inspections, regulators typically review:
- Deviation records
- Root cause investigations
- CAPA implementation
- Evidence of continuous quality improvement
Failure to manage deviations properly can result in compliance observations or regulatory actions.
TESKOQ’s Commitment to Quality
At TESKOQ, maintaining high standards of pharmacovigilance and quality compliance is a core priority. Through structured quality systems and continuous monitoring processes, TESKOQ aims to strengthen pharmacovigilance operations and support safe and effective healthcare solutions.
To learn more about TESKOQ’s commitment to pharmaceutical quality and innovation, visit www.teskoq.com.
Key Takeaways
- Deviation management is an essential part of pharmacovigilance quality systems.
- Deviations represent departures from approved procedures or regulatory requirements.
- Effective management involves documentation, investigation, and CAPA implementation.
- Strong deviation management systems support regulatory compliance and patient safety.
Related Articles
User Research in Life Sciences
Learn how patient insights are shaping next-generation therapeutics.
Read More...
Accelerating Drug Discovery
Discover how our new platform speeds up development timelines.
Read More...
Inside Our Clinical Labs
A behind-the-scenes look at our research and testing facilities.
Read More...